Understanding The Role of NADsYN1 in Cellular Processes and Potential Drug Targets

Target Name: NADSYN1

NCBI ID: G55191

Understanding The Role of NADsYN1 in Cellular Processes and Potential Drug Targets

NADsYN1 (FLJ10631) is a protein that is expressed in various tissues and cells throughout the body. It is a key regulator of the nuclear-cytoplasmic transport of NADs (nicotinamide adenine dinucleotide), which are essential co-factors for many cellular processes. In addition to its role in NAD homeostasis, NADsYN1 has also been shown to play a key role in the regulation of cellular processes such as cell growth, apoptosis, and inflammation.

The research on NADsYN1 has led to the identification of potential drug targets and biomarkers for the treatment of a variety of diseases. One of the main targets of NADsYN1 is the neurodegenerative disorder Alzheimer's disease, which is characterized by the progressive accumulation of neurofibrillary tangles and beta-amyloid plaques in the brain.

Studies have shown that NADsYN1 is highly expressed in the brains of individuals with Alzheimer's disease and that its levels are decreased in the brains of individuals with the disease compared to age-matched controls. In addition, animal models of Alzheimer's disease have shown that NADsYN1 overexpression can increase the formation of neurofibrillary tangles and beta-amyloid plaques, and that this increase in NAD levels is associated with the worsening of cognitive and behavioral symptoms in the animals.

Another potential drug target for NADsYN1 is the regulation of cell apoptosis, which is the process by which cells undergo programmed cell death. NADsYN1 has been shown to play a key role in the regulation of cell apoptosis, and its levels have been shown to decrease in the brains of individuals with Alzheimer's disease compared to age-matched controls. This loss of NADsYN1 has been linked to increased levels of pro-apoptotic protein, Bax, and increased brain infiltration of T-cells, which are known to contribute to the immune-mediated neurodegeneration seen in Alzheimer's disease.

NADsYN1 has also been shown to play a key role in the regulation of inflammation, which is a complex and important aspect of many diseases, including Alzheimer's disease. Studies have shown that NADsYN1 is highly expressed in the brains of individuals with inflammatory diseases, such as rheumatoid arthritis and multiple sclerosis, and that its levels are decreased in the brains of individuals with these diseases compared to age-matched controls. In addition, animal models of inflammatory diseases have shown that NADsYN1 overexpression can increase the production of pro-inflammatory cytokines and increase the infiltration of immune cells into the tissues, which is consistent with the known effects of these diseases on the immune system.

Despite the potential drug targets and biomarkers identified for NADsYN1, much research is still needed to fully understand its role in the regulation of cellular processes and its potential as a therapeutic drug. Further studies are needed to determine the exact mechanisms by which NADsYN1 regulates cellular processes and to identify potential drug targets for the treatment of diseases associated with its dysfunction.

In conclusion, NADsYN1 (FLJ10631) is a protein that plays a critical role in the regulation of nuclear-cytoplasmic transport of NADs and has been shown to be involved in a variety of cellular processes, including NAD homeostasis, cell growth, apoptosis, and inflammation. The potential drug targets and biomarkers identified for NADsYN1 make it an attractive target for the treatment of diseases associated with its dysfunction. Further research is needed to fully understand its role in the regulation of cellular processes and to identify potential therapeutic drug targets.

Protein Name: NAD Synthetase 1

Functions: Catalyzes the final step of the nicotinamide adenine dinucleotide (NAD) de novo synthesis pathway, the ATP-dependent amidation of deamido-NAD using L-glutamine as a nitrogen source

More Common Targets